in a key study it was the most promising of 83 anticancer agents tested in 14 patient-derived DIPG cell lines (Grasso et al, 2015. Nature Medicine 21(6), 555-559).
that's far too simplistic - most AIM share value is purely sentiment driven. Are you telling me the actual business was worth a third more than it is today on Monday because of anything tangible? Nope